Trial intelligence / Profile preview

Dutasteride with Ketoconazole and Hydrocortisone in Asymptomatic HRPC

NCT00673127Phase 2Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Feb 2005
Primary completion
Feb 2012
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by Beth Israel Deaconess Medical Center. Started Feb 2005; status: completed.

02

Drugs

dutasteride
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00673127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00673127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call